Management and outcomes of patients with unstable angina with undetectable, normal, or intermediate hsTnT levels

[1]  Xinkui Liu,et al.  Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking , 2020, BMC Complementary Medicine and Therapies.

[2]  H. Katus,et al.  RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction , 2019, European heart journal. Acute cardiovascular care.

[3]  Ò. Miró,et al.  Incidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarction , 2019, Heart.

[4]  Jeroen J. Bax,et al.  Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.

[5]  O. Barbarash,et al.  FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION , 2018, Fundamental and Clinical Medicine.

[6]  H. Schirmer,et al.  Pre-test characteristics of unstable angina patients with obstructive coronary artery disease confirmed by coronary angiography , 2018, Open Heart.

[7]  F. Apple,et al.  High-sensitivity cardiac troponin assays and unstable angina , 2018, European heart journal. Acute cardiovascular care.

[8]  B. Lindahl,et al.  Unstable Angina in the Era of Cardiac Troponin Assays with Improved Sensitivity-A Clinical Dilemma. , 2017, The American journal of medicine.

[9]  P. Armstrong,et al.  Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy , 2017, European heart journal. Acute cardiovascular care.

[10]  D. Newby,et al.  High-Sensitivity Troponin I Is Associated With High-Risk Plaque and MACE in Stable Coronary Artery Disease. , 2017, JACC. Cardiovascular imaging.

[11]  M. D. de Bruijne,et al.  Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review , 2016, Current cardiology reviews.

[12]  Marc P. Bonaca,et al.  High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. , 2017, Clinical chemistry.

[13]  K. Rentsch,et al.  Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction , 2016, European heart journal.

[14]  B. Lindahl,et al.  Consequences of implementing a cardiac troponin assay with improved sensitivity at Swedish coronary care units: an analysis from the SWEDEHEART registry. , 2016, European heart journal.

[15]  R. Ljung,et al.  Risk of revisits to the emergency department in admitted versus discharged patients with chest pain but without myocardial infarction in relation to high-sensitivity cardiac troponin T levels. , 2016, International journal of cardiology.

[16]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[17]  Baris Gencer,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .

[18]  K. Greaves,et al.  'Chest pain typicality' in suspected acute coronary syndromes and the impact of clinical experience. , 2015, The American journal of medicine.

[19]  K. Thygesen,et al.  Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays. , 2015, The American journal of medicine.

[20]  M. Isobe,et al.  Relationship Between Subclinical Cardiac Troponin I Elevation and Culprit Lesion Characteristics Assessed by Optical Coherence Tomography in Patients Undergoing Elective Percutaneous Coronary Intervention , 2015, Circulation. Cardiovascular interventions.

[21]  A. Jaffe,et al.  IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. , 2015, Clinical biochemistry.

[22]  A. Jaffe,et al.  A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .

[23]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[24]  E. Núñez,et al.  High-sensitivity versus conventional troponin for management and prognosis assessment of patients with acute chest pain , 2014, Heart.

[25]  C. Held,et al.  Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2014, Circulation.

[26]  H. Katus,et al.  Cardiac troponin level elevations not related to acute coronary syndromes , 2013, Nature Reviews Cardiology.

[27]  E. Braunwald,et al.  Unstable Angina: Is It Time for a Requiem? , 2013, Circulation.

[28]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[29]  Jeroen J. Bax,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .

[30]  Hugo A Katus,et al.  Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. , 2012, Clinical chemistry.

[31]  T. Lauer,et al.  Kardiologische Aspekte der präoperativen Risikostratifizierung , 2011 .

[32]  Kari Kuulasmaa,et al.  World Health Organization definition of myocardial infarction: 2008-09 revision. , 2011, International journal of epidemiology.

[33]  H. Kauczor,et al.  Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque , 2010, Heart.

[34]  B. Lindahl,et al.  The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. , 2010, American heart journal.

[35]  Luke K. Hermann,et al.  Comparison of frequency of inducible myocardial ischemia in patients presenting to emergency department with typical versus atypical or nonanginal chest pain. , 2010, The American journal of cardiology.

[36]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[37]  Stefan Blankenberg,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[38]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[39]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[40]  K. Eagle,et al.  Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) , 2006, BMJ : British Medical Journal.

[41]  R. Califf,et al.  Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. , 2006, Journal of the American College of Cardiology.

[42]  A. Kastrati,et al.  Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. , 2006, JAMA.

[43]  J. Tijssen,et al.  Early invasive versus selectively invasive management for acute coronary syndromes. , 2005, The New England journal of medicine.

[44]  R. D. de Winter,et al.  Plaque Instability Frequently Occurs Days or Weeks Before Occlusive Coronary Thrombosis: A Pathological Thrombectomy Study in Primary Percutaneous Coronary Intervention , 2005, Circulation.

[45]  M. Takano,et al.  Elevated Troponin T Levels and Lesion Characteristics in Non–ST-Elevation Acute Coronary Syndromes , 2004, Circulation.

[46]  L. Wallentin,et al.  The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. , 2002, American heart journal.

[47]  C. Hamm.  GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection , 2001 .

[48]  E. Antman,et al.  Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. , 2000, Journal of the American College of Cardiology.

[49]  L. Wallentin,et al.  Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. , 1997, Journal of the American College of Cardiology.

[50]  P. Serruys,et al.  Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. , 1995, Circulation.

[51]  E. Arbustini,et al.  Coronary thrombosis in non‐cardiac death , 1993, Coronary artery disease.